Drug Trial Radar · NCT05784441
A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
21
Actual
Start
Nov 6, 2023
Primary completion
Jan 6, 2027
Study completion Jan 3, 2040
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Mar 24, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this multicenter study is to test JNJ-90009530 in Relapsed or Refractory Non-Hodgkin Lymphoma Patients. The main questions the study aims to answer are: * can a dose of JNJ-90009530 be determined that is safe and well tolerated by patients. * will JNJ-90009530 help patients achieve a response and for how long?
Conditions
- Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Interventions
JNJ-90009530Drug
JNJ-90009530, an autologous Chimeric Antigen Receptor (CAR) - T therapy targeting CD20
Primary outcomes
What the sponsor says the trial is designed to measure.
- Calculate the Occurence of Adverse EventsTime frame: up to 24 months
- Determine Recommended Phase 2 dose (RP2D)Time frame: up to 24 months
Locations
15 sites in 4 countries. Site status is shown where the registry gives one.
University of Iowa Hospital
Iowa City, Iowa
University of Kentucky
Lexington, Kentucky
Mayo Clinic Rochester
Rochester, Minnesota
Rutgers University
New Brunswick, New Jersey
University Hospitals Cleveland Medical Center
Cleveland, Ohio
University of Pennsylvania
Philadelphia, Pennsylvania
MD Anderson Cancer Center
Houston, Texas
Royal Prince Alfred Hospital
Camperdown, Australia
Monash Medical Centre
Clayton, Australia
Austin Hospital
Heidelberg, Australia
Royal Brisbane and Women's Hospital
Herston, Australia
Westmead Hospital
Westmead, Australia
Hadassah Medical Center
Jerusalem, Israel
Sheba Medical Center
Ramat Gan, Israel
University College London Hospitals
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.